British American Tobacco (BATS): Nicotine Portfolio Fundamentals

Few companies in the FTSE 100 divide opinion as sharply as British American Tobacco. It is one of the largest cigarette manufacturers in the world, it generates enormous quantities of cash, it pays one of the index's most substantial dividends, and it operates in an industry whose core product is in structural, deliberate, policy-driven decline. Any serious British American Tobacco stock analysis therefore has to hold two ideas at once: a legacy business that is shrinking in volume but still highly profitable, and a newer smokeless nicotine business that is growing quickly from a much smaller base. This article walks through how the organisation actually makes its money, what the most recent reported numbers show, how the dividend and balance sheet fit together, and which risks genuinely move the needle.

How British American Tobacco Makes Its Money

BAT sells nicotine, and it does so through two broad channels. The first is combustibles: traditional cigarettes, sold under brands including Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans and, in the United States, Newport and Camel through its Reynolds American business. The second is what the company labels New Categories, covering three distinct smokeless formats: Vuse in vapour, Velo in modern oral nicotine pouches, and glo in heated tobacco.

The economics of the two halves are very different. Combustibles are a mature, slowly declining volume business, but pricing power and low incremental costs make them exceptionally profitable. New Categories are growing fast, require heavy investment in marketing and distribution, and have only recently begun contributing meaningfully to group profit rather than consuming it. Understanding the handover between the two is the central question in any assessment of the shares.

Geography matters as much as product. The United States is BAT's single most important profit pool, which is why competitive dynamics in American cigarettes — particularly the growth of deep-discount brands — carry disproportionate weight in the results. The group also has substantial positions across Europe, Asia-Pacific, the Middle East, Africa and Latin America, which brings meaningful currency translation effects into reported figures.

What the Latest Reported Numbers Show

BAT is a UK-listed company that reports in pounds sterling and publishes half-year and full-year results rather than quarterly accounts. Its most recent half-year report covered the six months to 30 June 2026 and was published on 30 July 2026.

In that period, group revenue was £12.3 billion, up 2.9% at constant currency, and adjusted profit from operations rose 3.5% to £5.4 billion. Adjusted diluted earnings per share increased 7.9% to 84p. The faster growth in earnings per share than in operating profit reflects lower net finance costs and the effect of share buybacks reducing the share count.

The smokeless business was the standout. New Categories revenue grew 18% in the half and reached 19.8% of group revenue, an increase of 160 basis points year on year. Within that, Velo — the modern oral pouch brand — grew revenue 66%, and Vuse returned to double-digit growth in the United States after a difficult period in which the vapour category was disrupted by illicit, largely unregulated disposable products.

The combustibles picture in the United States was more mixed. BAT's US volume share declined 80 basis points and value share fell 40 basis points amid continued growth in deep-discount cigarettes, though the company said it had held its US combustible volume share since January after stepping up investment behind its portfolio and commercial execution. Management reaffirmed full-year guidance for revenue and operating profit at the lower end of its mid-single-digit growth algorithm, and moved expected earnings per share growth towards the middle of its 5% to 8% range.

For context on the full-year shape of the business, the year ended 31 December 2025 produced revenue of £25,610 million — down 1.0% as reported but up 2.1% at constant currency — and adjusted profit from operations of £11,628 million, up 2.3% at constant currency, at an adjusted operating margin of 44.0%. New Categories revenue for that year was £3,621 million, up 7.0%, and the contribution those categories made to profit rose 77.1% to £442 million. Adjusted diluted earnings per share for 2025 were 340.5p.

That 44% adjusted operating margin is worth pausing on. It is the number that explains why a business selling a declining product can still fund a large dividend, a buyback and a substantial debt-reduction programme simultaneously.

Cash Generation, Dividend and the Balance Sheet

Cash conversion is central to the investment case, and the first half of 2026 was strong on that measure. Net cash from operating activities rose 47.3% to £3,402 million, and free cash flow before dividends increased 85.2% to £2,285 million. Half-year cash flows at BAT are seasonally uneven, so the percentage moves should be read alongside the full-year figures rather than annualised, but the direction supported the company's stated deleveraging plan.

On the dividend, BAT raised its 2025 declared dividend 2.0% to 245.04p per share, payable in four equal quarterly instalments of 61.26p in May 2026, August 2026, November 2026 and February 2027. Note the unit: these are pence, not pounds. With the shares trading in the region of 4,480p — that is, about £44.80 — in early August 2026, the declared 2025 dividend represents a yield in the mid-5% range. On the same share price and the 2025 adjusted diluted earnings per share of 340.5p, the shares change hands at roughly 13 times adjusted earnings. A market capitalisation of approximately £100 billion across around 2.16 billion shares in issue puts BAT among the largest companies on the London market.

The balance sheet carries real leverage. Adjusted net debt stood at £31,969 million at 30 June 2026, up 7.5%. The group targets leverage within a 2.0 to 2.5 times adjusted net debt to adjusted EBITDA corridor by the end of 2026. Alongside that, BAT has committed to a £1.3 billion share buy-back. Debt of this size is manageable while cash generation holds up and interest costs are contained; it is also the reason the pace of deleveraging is watched closely, because the dividend, the buyback and debt reduction all draw on the same pool of cash.

The Smokeless Transition and Why It Dominates the Debate

The strategic question facing BAT is straightforward to state and difficult to answer: can smokeless products grow profit fast enough to offset the long-run decline in cigarette volumes? At just under 20% of revenue and with New Categories contribution having grown sharply from a small base, the transition is real but incomplete. The great majority of group profit still comes from combustibles.

Each smokeless format carries a different profile:

• Modern oral (Velo) — currently the fastest-growing pillar, with 66% revenue growth in the first half of 2026. Nicotine pouches have relatively simple economics, no combustion and no device, which tends to support margins as scale builds.
• Vapour (Vuse) — a larger category by revenue but historically more volatile, heavily exposed to enforcement against illicit disposable vapes and to shifting flavour regulation, particularly in the United States.
• Heated tobacco (glo) — the smallest of the three for BAT and the one where competition is most entrenched, notably from Philip Morris International (PM) and its IQOS platform.

Investors comparing the sector will find that peers are running the same experiment with different weightings. Philip Morris International (PM) has pushed furthest into heated tobacco, Altria (MO) is concentrated in the US market, and Imperial Brands (IMB) has taken a more deliberately measured approach to New Categories. The variable to watch across all of them is not smokeless revenue growth in isolation but whether that revenue converts into profit at margins comparable to the cigarettes it is displacing.

Risks That Genuinely Matter

Some risks in this sector are perennial background noise; others can move the numbers materially.

• Regulation. Excise duty rises, flavour bans, nicotine caps, plain packaging and proposals for generational sales restrictions all directly affect volumes and pricing latitude. Regulation is not a tail risk here — it is a permanent operating condition, and it varies market by market.
• Litigation. The most significant recent resolution was in Canada, where on 6 March 2025 the Ontario Superior Court of Justice sanctioned plans of compromise and arrangement covering BAT's subsidiary Imperial Tobacco Canada alongside two other tobacco companies. The plans provide for an aggregate settlement of C$32.5 billion across the three companies, funded over time from the operating profits of the Canadian businesses, in exchange for a release of Canadian tobacco claims. This resolves a long-running overhang, but it also commits future Canadian profits.
• Illicit trade. Unregulated disposable vapes and deep-discount or counterfeit cigarettes take volume without paying duty, and they have already disrupted the vapour category. Enforcement intensity is largely outside the company's control.
• US competitive pressure. Given the weight of the United States in group profit, the 80 basis point volume share decline and the growth of deep-discount cigarettes reported in the first half of 2026 are more consequential than the headline size of the numbers suggests.
• Leverage and rates. With adjusted net debt near £32 billion, refinancing costs and the deleveraging trajectory interact directly with what is available for distributions.
• Currency. BAT reports in sterling but earns across many currencies. The gap between the 2025 reported revenue decline of 1.0% and the 2.1% constant-currency increase shows how much translation can obscure underlying trading.

What to Watch From Here

Rather than reaching for a conclusion, it is more useful to identify the specific data points that would change the picture in either direction.

• New Categories profitability, not just revenue. The share of revenue crossing 19.8% matters less than whether category contribution keeps compounding at the pace set in 2025.
• US combustible share stabilisation. Management said volume share had held since January 2026. Whether that persists through the second half is the single clearest test of whether the increased US investment is working.
• Leverage against the 2.0 to 2.5 times corridor. Reaching the target range by the end of 2026 would confirm that dividend, buyback and debt reduction can coexist; missing it would force a choice between them.
• Full-year delivery against guidance. Guidance is for revenue and operating profit at the lower end of the mid-single-digit algorithm with earnings per share growth towards the middle of 5% to 8%. The full-year results will show whether that held.
• Regulatory developments in the United States and Europe, particularly on vapour flavours and enforcement against illicit disposables, which shape the growth ceiling for Vuse.
• Free cash flow across the full year, given the seasonal unevenness of half-year cash flows.

Conclusion

A British American Tobacco stock analysis ultimately comes down to a question of arithmetic and timing rather than sentiment. The combustibles business remains extraordinarily profitable — a 44.0% adjusted operating margin in 2025 is unusual in any consumer sector — and it funds a dividend of 245.04p per share, a £1.3 billion buyback and a deleveraging programme at the same time. The smokeless business is growing quickly, reached 19.8% of revenue in the first half of 2026, and has begun converting growth into profit contribution. Set against that are a heavy debt load of nearly £32 billion, a permanent and tightening regulatory environment, litigation commitments that claim future profits, and competitive pressure in the United States that has cost volume share.

None of those facts settles the matter on their own. What they do is define the variables. Whether the smokeless transition outruns combustible decline, whether US share stabilises, and whether leverage falls into the target corridor are all measurable, and each will be visible in the next set of reported figures. Readers following the shares are better served tracking those specific numbers as they are published than relying on any general characterisation of the industry's direction.